Primary |
Helicobacter Gastritis |
45.0% |
Back Pain |
15.0% |
Gastrooesophageal Reflux Disease |
10.0% |
Hypertensive Heart Disease |
10.0% |
Pain In Extremity |
10.0% |
Diabetes Mellitus |
5.0% |
Dyslipidaemia |
5.0% |
|
Erythema |
20.0% |
Shock |
20.0% |
Acute Psychosis |
10.0% |
Disorientation |
10.0% |
Dyspnoea |
10.0% |
Folliculitis |
10.0% |
Hypertensive Heart Disease |
10.0% |
Suicide Attempt |
10.0% |
|
Secondary |
Helicobacter Infection |
29.3% |
Drug Use For Unknown Indication |
19.5% |
Gastrooesophageal Reflux Disease |
14.6% |
Helicobacter Gastritis |
14.6% |
Diabetes Mellitus |
4.9% |
Dyslipidaemia |
4.9% |
Hypertensive Heart Disease |
4.9% |
Benign Prostatic Hyperplasia |
2.4% |
Lung Disorder |
2.4% |
Product Used For Unknown Indication |
2.4% |
|
Erythema |
33.3% |
Respiration Abnormal |
33.3% |
Hypertensive Heart Disease |
16.7% |
Platelet Count Decreased |
16.7% |
|
Concomitant |
Drug Use For Unknown Indication |
35.5% |
Prophylaxis |
8.1% |
Multiple Myeloma |
5.6% |
Atrial Fibrillation |
5.3% |
Non-hodgkin's Lymphoma |
5.3% |
Product Used For Unknown Indication |
5.3% |
Rheumatoid Arthritis |
4.1% |
Pain |
3.8% |
Mesothelioma |
3.6% |
Acute Myeloid Leukaemia |
3.0% |
Hypertension |
2.8% |
Premedication |
2.5% |
Tachycardia Paroxysmal |
2.5% |
Lupus Nephritis |
2.3% |
Breast Cancer |
2.0% |
Thrombosis Prophylaxis |
2.0% |
Ankylosing Spondylitis |
1.5% |
Colorectal Cancer |
1.5% |
Prophylaxis Against Gastrointestinal Ulcer |
1.5% |
Sepsis |
1.5% |
|
Renal Failure Acute |
13.0% |
Folliculitis |
6.5% |
Respiratory Failure |
6.5% |
Cerebral Haemorrhage |
5.2% |
Hypertension |
5.2% |
Pyrexia |
5.2% |
Transaminases Increased |
5.2% |
Urticaria |
5.2% |
Vomiting |
5.2% |
Activated Partial Thromboplastin Time Prolonged |
3.9% |
Coombs Positive Haemolytic Anaemia |
3.9% |
Device Breakage |
3.9% |
Enteritis |
3.9% |
Pneumonia |
3.9% |
Pulmonary Embolism |
3.9% |
Sepsis |
3.9% |
Skin Hyperpigmentation |
3.9% |
Subileus |
3.9% |
Tongue Disorder |
3.9% |
Tooth Extraction |
3.9% |
|